Successful Anal Preservation by Neoadjuvant Imatinib Mesylate Treatment for Resection of Rectal Gastrointestinal Stromal Tumor (GIST): A Case Report-Reference-Cited by-同舟云学术

Successful Anal Preservation by Neoadjuvant Imatinib Mesylate Treatment for Resection of Rectal Gastrointestinal Stromal Tumor (GIST): A Case Report

Published:2016 Issue:4 Volume:41 Page:672-679
ISSN:0385-7883
Container-title:Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
language:en
Short-container-title:JJCS

Author:

Kosuge Makoto¹,Eto Ken¹,Hashizume Ryousuke¹,Takeda Mitsumasa¹,Uno Yoshiko¹,Hiramoto Yuki¹,Neki Kai¹,Kitagawa Kazuo¹,Mitsumori Norio¹,Yanaga Katsuhiko¹

Affiliation:

1. Department of Surgery, The Jikei University School of Medicine

Publisher

Japanese College of Surgeons

Subject

Cell Biology,Developmental Biology,Embryology,Anatomy

Link

https://www.jstage.jst.go.jp/article/jjcs/41/4/41_672/_pdf

Reference15 articles.

1. 1) Miettinen M, Furlong M, Salomo-Rikala M, et al:Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus:a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 25:1121-1133, 2001

2. 2) Demetri GD, von Mehren M, Blanke CD, et al:Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480, 2002

3. 4) Miettinen M, Lasota J:Gastrointestinal stromal tumors:pathology and prognosis at different sites. Semin Diagn Pathol 23:70-83, 2006

4. 6) Miettinen M, Lasota J:Gastrointestinal stromal tumors (GISTs):definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol 54:3-24, 2003

5. 8) Eisenberg BL, Harris J, Blanke CD, et al:Phase Ⅱ trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primaly and metastatic/recurrent operable gastrointestinal stromal tumor (GIST):early results of RTOG 0132/ACRIN 6665. J Surg Oncol 99:42-47, 2009